Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
Neurocrine Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 9, 2021
In 2020, five executives at Neurocrine Biosciences received on average a compensation package of $8M, a 35% increase compared to previous year.
Average pay of disclosed executives at Neurocrine Biosciences Kevin C. Gorman, Chief Executive Officer, received $14M in total, which increased by 47% compared to 2019. 51% of Gorman's compensation, or $7.1M, was in option awards. Gorman also received $543K in bonus, $775K in salary, $5.4M in stock awards, as well as $63K in other compensation.
For fiscal year 2020, the median employee pay was $241,848 at Neurocrine Biosciences. Therefore, the ratio of Kevin C. Gorman's pay to the median employee pay was 57 to one.
Kyle W. Gano, Chief Development and Strategy Officer, received a compensation package of $7.2M, which increased by 53% compared to previous year. 52% of the compensation package, or $3.7M, was in option awards. Eric Benevich, Chief Commercial Officer, earned $6.7M in 2020, a 16% increase compared to previous year. Matthew C. Abernethy, Chief Financial Officer, received $6.3M in 2020, which increases by 8% compared to 2019. Eiry W. Roberts, Chief Medical Officer, earned $5.8M in 2020, a 19% increase compared to previous year.
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Development and Strategy Officer
Chief Medical Officer
You may also like